EcoDrugPlus

Kinesin Family Member 5b

Ensembl ID : ENSMZEG00005004182
Gene Symbol: KIF5B
1 Cross references
235 Possible Orthologues:

Kinesin Family Member 5b

Ensembl ID : ENSMZEG00005005155
Gene Symbol: KIF5B
4 Cross references
235 Possible Orthologues:

Leukotriene A4 Hydrolase

Ensembl ID : ENSMZEG00005014990
Gene Symbol: LTA4H
3 Cross references
203 Possible Orthologues:

Leukotriene B4 Receptor 1

Ensembl ID : ENSMZEG00005020664
Gene Symbol: LOC101476279
3 Cross references
156 Possible Orthologues:

Leukotriene B4 Receptor 1

Ensembl ID : ENSMZEG00005024190
Gene Symbol: LOC101467388
3 Cross references
157 Possible Orthologues:

Leukotriene B4 Receptor 1

Ensembl ID : ENSMZEG00005020667
Gene Symbol: LOC101476568
3 Cross references
142 Possible Orthologues:

Lutropin-Choriogonadotropic Hormone Receptor

Ensembl ID : ENSMZEG00005002353
Gene Symbol: LOC101485007
4 Cross references
200 Possible Orthologues:

Lysine Demethylase 1a

Ensembl ID : ENSMZEG00005003449
Gene Symbol: KDM1A
3 Cross references
212 Possible Orthologues:

Lysyl Oxidase Homolog 2a

Ensembl ID : ENSMZEG00005026914
Gene Symbol: LOC101480930
3 Cross references
209 Possible Orthologues:

Lysyl Oxidase Homolog 2b

Ensembl ID : ENSMZEG00005005018
Gene Symbol: LOC101463685
3 Cross references
213 Possible Orthologues:

Macrophage Colony-Stimulating Factor 1 Receptor 2

Ensembl ID : ENSMZEG00005024946
Gene Symbol: LOC101466356
2 Cross references
204 Possible Orthologues:

Macrophage Migration Inhibitory Factor

Ensembl ID : ENSMZEG00005002529
Gene Symbol: MIF
3 Cross references
229 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).